| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 183 | 2021 | 1219 | 13.350 |
Why?
|
| Pseudomonas Infections | 97 | 2021 | 613 | 9.750 |
Why?
|
| Antibodies, Bacterial | 101 | 2023 | 1470 | 9.160 |
Why?
|
| Acetylglucosamine | 32 | 2021 | 191 | 8.150 |
Why?
|
| Polysaccharides, Bacterial | 86 | 2020 | 578 | 6.110 |
Why?
|
| Bacterial Vaccines | 32 | 2021 | 403 | 5.060 |
Why?
|
| Staphylococcus aureus | 41 | 2020 | 1451 | 4.690 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 28 | 2012 | 437 | 3.880 |
Why?
|
| Cystic Fibrosis | 52 | 2021 | 1177 | 3.510 |
Why?
|
| beta-Glucans | 17 | 2020 | 123 | 3.270 |
Why?
|
| Lipopolysaccharides | 56 | 2012 | 2216 | 3.260 |
Why?
|
| Biofilms | 35 | 2020 | 617 | 3.240 |
Why?
|
| Staphylococcus epidermidis | 26 | 2016 | 117 | 3.170 |
Why?
|
| Staphylococcal Infections | 33 | 2018 | 1400 | 3.110 |
Why?
|
| Antigens, Bacterial | 39 | 2021 | 1171 | 2.730 |
Why?
|
| Bacterial Adhesion | 33 | 2012 | 316 | 2.520 |
Why?
|
| Pneumonia, Bacterial | 15 | 2021 | 316 | 2.420 |
Why?
|
| Keratitis | 12 | 2021 | 268 | 2.240 |
Why?
|
| Actinomycetales Infections | 6 | 2021 | 30 | 2.200 |
Why?
|
| Opsonin Proteins | 29 | 2019 | 150 | 2.200 |
Why?
|
| Exotoxins | 7 | 2013 | 119 | 2.020 |
Why?
|
| Horse Diseases | 6 | 2021 | 57 | 2.000 |
Why?
|
| Pseudomonas Vaccines | 6 | 2012 | 23 | 1.880 |
Why?
|
| Leukocidins | 5 | 2013 | 17 | 1.790 |
Why?
|
| O Antigens | 19 | 2010 | 193 | 1.750 |
Why?
|
| Rhodococcus equi | 6 | 2021 | 16 | 1.740 |
Why?
|
| Bacterial Capsules | 13 | 2018 | 251 | 1.690 |
Why?
|
| Immunization, Passive | 28 | 2021 | 623 | 1.620 |
Why?
|
| Virulence Factors | 13 | 2020 | 509 | 1.620 |
Why?
|
| Bacterial Toxins | 11 | 2013 | 931 | 1.540 |
Why?
|
| Eye Infections, Bacterial | 10 | 2018 | 235 | 1.530 |
Why?
|
| Phagocytosis | 39 | 2019 | 1539 | 1.480 |
Why?
|
| Pneumonia, Staphylococcal | 3 | 2015 | 43 | 1.320 |
Why?
|
| Antibodies, Monoclonal | 33 | 2019 | 9274 | 1.310 |
Why?
|
| Vaccines, Conjugate | 10 | 2018 | 333 | 1.280 |
Why?
|
| Escherichia coli Infections | 5 | 2015 | 532 | 1.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 14 | 2017 | 1122 | 1.270 |
Why?
|
| Bacterial Proteins | 25 | 2021 | 3848 | 1.250 |
Why?
|
| Staphylococcal Vaccines | 5 | 2012 | 30 | 1.180 |
Why?
|
| Yersinia pestis | 9 | 2012 | 33 | 1.170 |
Why?
|
| Mice | 156 | 2023 | 81183 | 1.100 |
Why?
|
| Rabbits | 41 | 2017 | 4894 | 1.090 |
Why?
|
| Mice, Inbred C3H | 27 | 2012 | 964 | 1.080 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 5 | 2013 | 687 | 1.070 |
Why?
|
| Escherichia coli Vaccines | 2 | 2015 | 11 | 1.040 |
Why?
|
| Animals | 212 | 2023 | 168757 | 1.040 |
Why?
|
| Oligosaccharides | 11 | 2012 | 414 | 0.970 |
Why?
|
| Virulence | 30 | 2019 | 1333 | 0.970 |
Why?
|
| Glycosaminoglycans | 17 | 2008 | 624 | 0.930 |
Why?
|
| Cornea | 15 | 2016 | 1524 | 0.910 |
Why?
|
| Immunoglobulin G | 28 | 2019 | 4560 | 0.890 |
Why?
|
| Alginates | 12 | 2011 | 252 | 0.880 |
Why?
|
| Vaccination | 14 | 2021 | 3278 | 0.880 |
Why?
|
| Flagellin | 3 | 2017 | 125 | 0.850 |
Why?
|
| Streptococcus equi | 2 | 2020 | 9 | 0.820 |
Why?
|
| Immunoglobulin Km Allotypes | 1 | 2021 | 1 | 0.820 |
Why?
|
| Immunoglobulin Gm Allotypes | 1 | 2021 | 2 | 0.820 |
Why?
|
| Bacterial Infections | 8 | 2020 | 1401 | 0.820 |
Why?
|
| Corneal Ulcer | 7 | 2012 | 169 | 0.810 |
Why?
|
| Salmonella typhi | 5 | 2016 | 201 | 0.800 |
Why?
|
| Disease Models, Animal | 38 | 2021 | 18029 | 0.770 |
Why?
|
| Bacteremia | 10 | 2013 | 962 | 0.770 |
Why?
|
| Conjunctivitis, Bacterial | 2 | 2018 | 24 | 0.750 |
Why?
|
| Neutrophils | 17 | 2021 | 3719 | 0.740 |
Why?
|
| Carbohydrate Sequence | 20 | 2012 | 414 | 0.740 |
Why?
|
| Horses | 8 | 2021 | 304 | 0.730 |
Why?
|
| Epithelial Cells | 17 | 2012 | 3690 | 0.710 |
Why?
|
| Drug Resistance, Bacterial | 7 | 2022 | 1035 | 0.710 |
Why?
|
| Acinetobacter baumannii | 7 | 2020 | 107 | 0.710 |
Why?
|
| Staphylococcus | 5 | 2005 | 155 | 0.710 |
Why?
|
| Community-Acquired Infections | 3 | 2013 | 465 | 0.680 |
Why?
|
| Streptococcal Infections | 2 | 2020 | 638 | 0.680 |
Why?
|
| Enterococcus faecalis | 5 | 2019 | 251 | 0.670 |
Why?
|
| Immunization | 19 | 2020 | 1256 | 0.660 |
Why?
|
| Neutropenia | 10 | 2012 | 895 | 0.660 |
Why?
|
| Immunity, Innate | 13 | 2013 | 2958 | 0.650 |
Why?
|
| Pneumonia | 12 | 2021 | 2133 | 0.650 |
Why?
|
| Gastrointestinal Tract | 4 | 2015 | 814 | 0.630 |
Why?
|
| Epithelium, Corneal | 4 | 2013 | 247 | 0.630 |
Why?
|
| Adhesins, Bacterial | 7 | 2012 | 119 | 0.620 |
Why?
|
| DNA Transposable Elements | 7 | 2017 | 748 | 0.620 |
Why?
|
| Membrane Microdomains | 5 | 2013 | 203 | 0.620 |
Why?
|
| Vaccines, Attenuated | 9 | 2012 | 342 | 0.590 |
Why?
|
| Antibody Specificity | 13 | 2012 | 1095 | 0.590 |
Why?
|
| Coagulase | 6 | 2012 | 54 | 0.580 |
Why?
|
| Vancomycin | 5 | 2014 | 501 | 0.580 |
Why?
|
| Fungal Vaccines | 1 | 2016 | 7 | 0.570 |
Why?
|
| Eye Infections | 2 | 2014 | 64 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 33 | 2021 | 21827 | 0.550 |
Why?
|
| Eye Infections, Fungal | 1 | 2016 | 110 | 0.530 |
Why?
|
| Immunity, Cellular | 9 | 2016 | 1607 | 0.520 |
Why?
|
| Lung | 28 | 2018 | 9856 | 0.510 |
Why?
|
| Colony Count, Microbial | 10 | 2015 | 331 | 0.510 |
Why?
|
| Antilymphocyte Serum | 1 | 2016 | 492 | 0.510 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 3 | 2013 | 108 | 0.500 |
Why?
|
| Malaria Vaccines | 1 | 2016 | 158 | 0.500 |
Why?
|
| Hexuronic Acids | 7 | 2011 | 144 | 0.500 |
Why?
|
| Glucuronic Acid | 7 | 2011 | 148 | 0.500 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 169 | 0.490 |
Why?
|
| Flagella | 2 | 2017 | 103 | 0.490 |
Why?
|
| Bronchi | 3 | 2008 | 840 | 0.490 |
Why?
|
| Shiga Toxin | 1 | 2014 | 34 | 0.480 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2014 | 28 | 0.480 |
Why?
|
| Escherichia coli | 11 | 2023 | 4217 | 0.470 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 187 | 0.470 |
Why?
|
| beta-Lactamases | 1 | 2016 | 306 | 0.470 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 18 | 2016 | 3870 | 0.460 |
Why?
|
| Genes, Bacterial | 10 | 2017 | 1079 | 0.460 |
Why?
|
| Porins | 1 | 2013 | 81 | 0.460 |
Why?
|
| Complement C3 | 6 | 2009 | 461 | 0.460 |
Why?
|
| Anti-Infective Agents, Urinary | 2 | 2010 | 28 | 0.450 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 497 | 0.450 |
Why?
|
| Animals, Newborn | 8 | 2021 | 2726 | 0.450 |
Why?
|
| Intestines | 3 | 2019 | 1924 | 0.450 |
Why?
|
| Fucose | 2 | 2003 | 125 | 0.440 |
Why?
|
| Respiratory Tract Infections | 6 | 2009 | 961 | 0.440 |
Why?
|
| Galactans | 1 | 2012 | 31 | 0.440 |
Why?
|
| Blood Bactericidal Activity | 12 | 2017 | 126 | 0.430 |
Why?
|
| Carbapenems | 1 | 2013 | 118 | 0.430 |
Why?
|
| Microscopy, Confocal | 10 | 2012 | 1970 | 0.430 |
Why?
|
| Carbohydrate Conformation | 12 | 2018 | 208 | 0.430 |
Why?
|
| Amidohydrolases | 2 | 2018 | 169 | 0.420 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2010 | 75 | 0.420 |
Why?
|
| Respiratory Mucosa | 3 | 2012 | 427 | 0.420 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 359 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 35 | 2019 | 6386 | 0.410 |
Why?
|
| Epitopes | 15 | 2009 | 2571 | 0.410 |
Why?
|
| Caveolin 1 | 2 | 2009 | 263 | 0.390 |
Why?
|
| Interleukin-17 | 4 | 2016 | 899 | 0.380 |
Why?
|
| Bacteria | 6 | 2023 | 2114 | 0.380 |
Why?
|
| Gene Library | 1 | 2013 | 1074 | 0.370 |
Why?
|
| Acinetobacter Infections | 4 | 2017 | 69 | 0.370 |
Why?
|
| Antibodies, Neutralizing | 4 | 2014 | 1978 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 15 | 2016 | 7181 | 0.370 |
Why?
|
| Teichoic Acids | 6 | 2008 | 66 | 0.360 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2010 | 66 | 0.360 |
Why?
|
| Eye | 1 | 2014 | 729 | 0.360 |
Why?
|
| Mycoses | 1 | 2013 | 376 | 0.360 |
Why?
|
| Immune Sera | 9 | 2012 | 641 | 0.360 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2010 | 109 | 0.360 |
Why?
|
| Ion Transport | 1 | 2011 | 320 | 0.350 |
Why?
|
| Lung Diseases | 7 | 2012 | 1886 | 0.350 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2010 | 427 | 0.340 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 713 | 0.340 |
Why?
|
| Sepsis | 9 | 2016 | 2593 | 0.330 |
Why?
|
| Soft Tissue Infections | 1 | 2010 | 155 | 0.330 |
Why?
|
| Intestinal Mucosa | 4 | 2010 | 3036 | 0.330 |
Why?
|
| Neutrophil Infiltration | 2 | 2018 | 390 | 0.330 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 3597 | 0.330 |
Why?
|
| Immunotherapy | 8 | 2023 | 4445 | 0.330 |
Why?
|
| Molecular Sequence Data | 22 | 2012 | 18111 | 0.320 |
Why?
|
| Humans | 155 | 2021 | 744343 | 0.320 |
Why?
|
| Molecular Weight | 21 | 2005 | 2255 | 0.320 |
Why?
|
| Enterococcus faecium | 2 | 1999 | 102 | 0.320 |
Why?
|
| beta-Cyclodextrins | 2 | 2008 | 64 | 0.310 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2009 | 571 | 0.310 |
Why?
|
| ADP Ribose Transferases | 2 | 2007 | 90 | 0.310 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2007 | 11 | 0.310 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2010 | 639 | 0.310 |
Why?
|
| Plague Vaccine | 4 | 2009 | 4 | 0.300 |
Why?
|
| Peritonitis | 1 | 2009 | 365 | 0.300 |
Why?
|
| Mucous Membrane | 3 | 2008 | 673 | 0.300 |
Why?
|
| Female | 88 | 2021 | 380194 | 0.300 |
Why?
|
| Escherichia coli Proteins | 3 | 2018 | 1050 | 0.290 |
Why?
|
| Carrier State | 2 | 2010 | 518 | 0.290 |
Why?
|
| Urinary Tract Infections | 2 | 2010 | 788 | 0.290 |
Why?
|
| NF-kappa B | 6 | 2007 | 2499 | 0.280 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2866 | 0.280 |
Why?
|
| Mice, Inbred A | 2 | 2018 | 248 | 0.280 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2007 | 262 | 0.270 |
Why?
|
| Superantigens | 4 | 1987 | 129 | 0.270 |
Why?
|
| Mutation | 21 | 2019 | 29786 | 0.260 |
Why?
|
| Corneal Diseases | 3 | 1997 | 636 | 0.260 |
Why?
|
| Candidiasis | 1 | 2008 | 366 | 0.260 |
Why?
|
| Magnetic Resonance Spectroscopy | 14 | 2011 | 3760 | 0.260 |
Why?
|
| Antibody Formation | 6 | 2021 | 1402 | 0.250 |
Why?
|
| Candida albicans | 1 | 2008 | 394 | 0.250 |
Why?
|
| Cell Line | 13 | 2017 | 15997 | 0.250 |
Why?
|
| Burkholderia Infections | 2 | 2017 | 44 | 0.250 |
Why?
|
| G(M1) Ganglioside | 2 | 2004 | 96 | 0.250 |
Why?
|
| Teicoplanin | 1 | 2004 | 27 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 5 | 2012 | 1369 | 0.240 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 9438 | 0.240 |
Why?
|
| Species Specificity | 10 | 2017 | 2478 | 0.240 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2004 | 421 | 0.240 |
Why?
|
| Glucosamine | 3 | 2011 | 132 | 0.240 |
Why?
|
| Complement System Proteins | 7 | 2008 | 795 | 0.230 |
Why?
|
| Nasal Mucosa | 1 | 2006 | 373 | 0.230 |
Why?
|
| Phosphotransferases (Phosphomutases) | 2 | 1993 | 7 | 0.230 |
Why?
|
| Endotoxins | 2 | 2003 | 527 | 0.230 |
Why?
|
| Host-Pathogen Interactions | 4 | 2016 | 1477 | 0.230 |
Why?
|
| Mice, Knockout | 10 | 2013 | 14557 | 0.230 |
Why?
|
| Cell Line, Transformed | 5 | 2008 | 898 | 0.230 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 972 | 0.230 |
Why?
|
| Mucus | 3 | 1994 | 321 | 0.230 |
Why?
|
| Metalloendopeptidases | 3 | 2003 | 396 | 0.220 |
Why?
|
| Malaria | 1 | 2013 | 1239 | 0.220 |
Why?
|
| Transcription, Genetic | 5 | 2010 | 7722 | 0.220 |
Why?
|
| Aminoglycosides | 2 | 2022 | 162 | 0.220 |
Why?
|
| Complement C1 | 2 | 2019 | 33 | 0.220 |
Why?
|
| Administration, Intranasal | 4 | 2010 | 446 | 0.210 |
Why?
|
| Macrophages, Alveolar | 2 | 2018 | 407 | 0.210 |
Why?
|
| Plague | 3 | 2007 | 22 | 0.210 |
Why?
|
| Plankton | 3 | 2006 | 21 | 0.210 |
Why?
|
| DNA, Bacterial | 7 | 2017 | 1465 | 0.210 |
Why?
|
| Interleukin-1 | 7 | 2011 | 1263 | 0.210 |
Why?
|
| Gene Deletion | 7 | 2017 | 2751 | 0.200 |
Why?
|
| Staphylococcus haemolyticus | 3 | 2005 | 6 | 0.200 |
Why?
|
| Bacterial Translocation | 3 | 2008 | 73 | 0.200 |
Why?
|
| Vaccines | 5 | 2003 | 822 | 0.200 |
Why?
|
| Plasmids | 4 | 2022 | 2307 | 0.200 |
Why?
|
| Acetylation | 4 | 2018 | 1085 | 0.200 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2007 | 276 | 0.200 |
Why?
|
| Epithelium | 9 | 1998 | 1679 | 0.200 |
Why?
|
| Enterotoxins | 4 | 1987 | 368 | 0.190 |
Why?
|
| Neisseria meningitidis | 5 | 2016 | 109 | 0.190 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 1028 | 0.190 |
Why?
|
| Osteomyelitis | 2 | 2017 | 402 | 0.190 |
Why?
|
| Glycoside Hydrolases | 3 | 2018 | 133 | 0.190 |
Why?
|
| Meningitis, Bacterial | 1 | 2023 | 218 | 0.190 |
Why?
|
| Myelopoiesis | 1 | 2021 | 133 | 0.190 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2019 | 341 | 0.190 |
Why?
|
| Flow Cytometry | 6 | 2016 | 5974 | 0.190 |
Why?
|
| Serotyping | 10 | 2008 | 338 | 0.190 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2021 | 55 | 0.180 |
Why?
|
| Phagocytes | 3 | 2012 | 297 | 0.180 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2016 | 567 | 0.180 |
Why?
|
| Pharynx | 1 | 2003 | 413 | 0.180 |
Why?
|
| Mouth | 1 | 2003 | 374 | 0.180 |
Why?
|
| Tetanus Toxoid | 1 | 2020 | 193 | 0.180 |
Why?
|
| Microbial Viability | 2 | 2014 | 234 | 0.180 |
Why?
|
| Interleukins | 2 | 2015 | 791 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2014 | 2557 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2008 | 880 | 0.180 |
Why?
|
| Vancomycin Resistance | 1 | 2000 | 128 | 0.180 |
Why?
|
| Cytotoxins | 1 | 2000 | 153 | 0.180 |
Why?
|
| Immunoglobulin A | 5 | 1998 | 992 | 0.180 |
Why?
|
| Microarray Analysis | 2 | 2020 | 767 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2006 | 6544 | 0.170 |
Why?
|
| Endocytosis | 2 | 2009 | 985 | 0.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 794 | 0.170 |
Why?
|
| Chromatography, Gel | 3 | 2012 | 668 | 0.170 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 552 | 0.170 |
Why?
|
| Temperature | 4 | 2012 | 2206 | 0.170 |
Why?
|
| Antigens, Surface | 7 | 2018 | 1663 | 0.170 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 1996 | 64 | 0.170 |
Why?
|
| Glycomics | 1 | 2020 | 121 | 0.170 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 186 | 0.160 |
Why?
|
| Bordetella | 1 | 2018 | 5 | 0.160 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2009 | 39 | 0.160 |
Why?
|
| Lipid A | 5 | 2009 | 67 | 0.160 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 2012 | 404 | 0.160 |
Why?
|
| Cecum | 2 | 2011 | 237 | 0.160 |
Why?
|
| Disease Susceptibility | 5 | 2009 | 1782 | 0.160 |
Why?
|
| Dose-Response Relationship, Immunologic | 8 | 1997 | 370 | 0.160 |
Why?
|
| Artifacts | 1 | 2006 | 1904 | 0.150 |
Why?
|
| Acetylesterase | 1 | 2017 | 14 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2010 | 2942 | 0.150 |
Why?
|
| Genome, Bacterial | 3 | 2019 | 760 | 0.150 |
Why?
|
| Models, Biological | 4 | 2020 | 9583 | 0.150 |
Why?
|
| Equipment Contamination | 3 | 2012 | 185 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 425 | 0.150 |
Why?
|
| Transport Vesicles | 1 | 2018 | 83 | 0.150 |
Why?
|
| Nociceptors | 1 | 2021 | 432 | 0.150 |
Why?
|
| Drug Resistance, Microbial | 6 | 2015 | 862 | 0.150 |
Why?
|
| Respiratory System | 3 | 1996 | 557 | 0.150 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 1998 | 171 | 0.150 |
Why?
|
| Cells, Cultured | 10 | 2013 | 19229 | 0.150 |
Why?
|
| Symporters | 1 | 2000 | 362 | 0.150 |
Why?
|
| Catheters, Indwelling | 3 | 1995 | 426 | 0.150 |
Why?
|
| Haemophilus influenzae | 3 | 2008 | 171 | 0.150 |
Why?
|
| Male | 37 | 2021 | 350118 | 0.150 |
Why?
|
| Disulfides | 1 | 2019 | 457 | 0.150 |
Why?
|
| Mucins | 3 | 1994 | 564 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 853 | 0.140 |
Why?
|
| Complement Pathway, Alternative | 3 | 2017 | 126 | 0.140 |
Why?
|
| Culture Media | 3 | 2014 | 908 | 0.140 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.140 |
Why?
|
| Complement Activation | 4 | 2001 | 453 | 0.140 |
Why?
|
| Isomerases | 2 | 1993 | 56 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2002 | 3748 | 0.140 |
Why?
|
| Biosynthetic Pathways | 2 | 2015 | 137 | 0.140 |
Why?
|
| Base Sequence | 5 | 2012 | 12797 | 0.140 |
Why?
|
| Periprosthetic Fractures | 1 | 2017 | 62 | 0.140 |
Why?
|
| Operon | 4 | 2018 | 363 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 3505 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2012 | 758 | 0.140 |
Why?
|
| DNA Primers | 3 | 2012 | 2892 | 0.140 |
Why?
|
| Cytokines | 5 | 2017 | 7322 | 0.140 |
Why?
|
| Spleen | 6 | 2016 | 2362 | 0.130 |
Why?
|
| Vaccines, Synthetic | 4 | 2020 | 634 | 0.130 |
Why?
|
| Polysaccharides | 3 | 2016 | 1053 | 0.130 |
Why?
|
| Fimbriae Proteins | 1 | 2015 | 134 | 0.130 |
Why?
|
| Survival Analysis | 4 | 2013 | 10252 | 0.130 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1991 | 349 | 0.120 |
Why?
|
| Guinea Pigs | 9 | 2007 | 1386 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 3 | 1993 | 517 | 0.120 |
Why?
|
| Point Mutation | 3 | 2009 | 1623 | 0.120 |
Why?
|
| Genotype | 5 | 2021 | 12951 | 0.120 |
Why?
|
| HL-60 Cells | 1 | 2015 | 365 | 0.120 |
Why?
|
| Digestive System | 1 | 1995 | 253 | 0.120 |
Why?
|
| Trachea | 3 | 2001 | 1076 | 0.120 |
Why?
|
| Typhoid Fever | 1 | 2016 | 197 | 0.120 |
Why?
|
| Streptococcus agalactiae | 1 | 2016 | 375 | 0.120 |
Why?
|
| Mice, Inbred Strains | 4 | 2007 | 1827 | 0.120 |
Why?
|
| Models, Immunological | 2 | 2012 | 527 | 0.120 |
Why?
|
| Amidines | 1 | 2013 | 30 | 0.120 |
Why?
|
| Immunoglobulin M | 3 | 1995 | 1537 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 2 | 1995 | 455 | 0.120 |
Why?
|
| Gene Silencing | 3 | 2009 | 1538 | 0.120 |
Why?
|
| Antitoxins | 1 | 2014 | 81 | 0.120 |
Why?
|
| Bacterial Load | 1 | 2014 | 153 | 0.120 |
Why?
|
| Catheterization | 3 | 1998 | 1470 | 0.120 |
Why?
|
| Cyclophosphamide | 5 | 2008 | 2242 | 0.120 |
Why?
|
| Mastitis, Bovine | 1 | 2013 | 11 | 0.110 |
Why?
|
| Gentian Violet | 1 | 2013 | 31 | 0.110 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 2005 | 89 | 0.110 |
Why?
|
| Epidermis | 1 | 2016 | 528 | 0.110 |
Why?
|
| Immunochemistry | 2 | 2003 | 124 | 0.110 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1991 | 201 | 0.110 |
Why?
|
| Protein Binding | 5 | 2019 | 9386 | 0.110 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2013 | 53 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2004 | 2924 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2014 | 1155 | 0.110 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 1992 | 12 | 0.110 |
Why?
|
| Siphonaptera | 1 | 2012 | 7 | 0.110 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 25 | 0.110 |
Why?
|
| Blood-Air Barrier | 1 | 2012 | 25 | 0.110 |
Why?
|
| Congo Red | 1 | 2012 | 46 | 0.110 |
Why?
|
| Caveolins | 1 | 2013 | 104 | 0.110 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2012 | 62 | 0.110 |
Why?
|
| Apoptosis | 3 | 2004 | 9727 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2015 | 1877 | 0.110 |
Why?
|
| Drug Tolerance | 1 | 2014 | 376 | 0.110 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 714 | 0.110 |
Why?
|
| Goats | 1 | 2012 | 171 | 0.110 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7880 | 0.110 |
Why?
|
| Macrophages | 8 | 2013 | 5655 | 0.110 |
Why?
|
| Polymyxin B | 3 | 2007 | 46 | 0.110 |
Why?
|
| Burkholderia cepacia complex | 1 | 2012 | 25 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 184 | 0.100 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2012 | 80 | 0.100 |
Why?
|
| Plasmodium berghei | 1 | 2013 | 168 | 0.100 |
Why?
|
| Carbamates | 1 | 2013 | 196 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2012 | 102 | 0.100 |
Why?
|
| Human Experimentation | 1 | 2012 | 127 | 0.100 |
Why?
|
| Penicillins | 1 | 2014 | 380 | 0.100 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1995 | 321 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 270 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 690 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2012 | 2375 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Methicillin Resistance | 1 | 2012 | 198 | 0.100 |
Why?
|
| Color | 1 | 2012 | 307 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 742 | 0.100 |
Why?
|
| Binding Sites, Antibody | 3 | 2004 | 349 | 0.100 |
Why?
|
| Gentamicins | 3 | 1996 | 255 | 0.100 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2011 | 318 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 2635 | 0.090 |
Why?
|
| Clinical Trials as Topic | 4 | 2016 | 7913 | 0.090 |
Why?
|
| Ceramides | 2 | 2010 | 199 | 0.090 |
Why?
|
| Fungi | 1 | 2013 | 327 | 0.090 |
Why?
|
| Molecular Structure | 4 | 2020 | 1899 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2011 | 1475 | 0.090 |
Why?
|
| Shock, Septic | 2 | 1987 | 775 | 0.090 |
Why?
|
| Immunoblotting | 3 | 2005 | 1682 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2016 | 4386 | 0.090 |
Why?
|
| Endocarditis | 1 | 1994 | 350 | 0.090 |
Why?
|
| Recombinant Proteins | 4 | 2004 | 6622 | 0.090 |
Why?
|
| Cross Infection | 3 | 2010 | 1416 | 0.090 |
Why?
|
| RNA, Bacterial | 1 | 2011 | 390 | 0.090 |
Why?
|
| Monosaccharides | 3 | 2003 | 70 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1993 | 1821 | 0.090 |
Why?
|
| Dicloxacillin | 2 | 2005 | 9 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 3846 | 0.090 |
Why?
|
| Binding Sites | 4 | 2003 | 6114 | 0.090 |
Why?
|
| Seroepidemiologic Studies | 1 | 2010 | 401 | 0.080 |
Why?
|
| Opportunistic Infections | 2 | 2004 | 389 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 1375 | 0.080 |
Why?
|
| Mastitis | 1 | 2009 | 41 | 0.080 |
Why?
|
| Biological Transport | 2 | 2005 | 2118 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 697 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 894 | 0.080 |
Why?
|
| Haemophilus Vaccines | 1 | 1989 | 69 | 0.080 |
Why?
|
| Hybridomas | 2 | 2004 | 452 | 0.080 |
Why?
|
| Nose | 1 | 2012 | 509 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 849 | 0.080 |
Why?
|
| T-Lymphocytes | 8 | 1993 | 10180 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2018 | 5456 | 0.080 |
Why?
|
| Mice, Inbred CFTR | 1 | 2008 | 19 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 3 | 2009 | 319 | 0.080 |
Why?
|
| Glycolipids | 1 | 2009 | 204 | 0.080 |
Why?
|
| Elastin | 1 | 2010 | 308 | 0.080 |
Why?
|
| 3-Phosphoshikimate 1-Carboxyvinyltransferase | 2 | 2005 | 6 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2011 | 558 | 0.080 |
Why?
|
| Microscopy, Electron | 4 | 1996 | 2645 | 0.080 |
Why?
|
| Pulmonary Alveoli | 2 | 2010 | 675 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1832 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 2274 | 0.080 |
Why?
|
| Acrylates | 2 | 2005 | 89 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2009 | 964 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
| Peptide Hydrolases | 2 | 2008 | 634 | 0.080 |
Why?
|
| Immunoglobulins | 4 | 2005 | 881 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2010 | 424 | 0.080 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 1988 | 188 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2008 | 2740 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 1836 | 0.080 |
Why?
|
| Mercury | 1 | 2010 | 285 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 1602 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 490 | 0.070 |
Why?
|
| Thrombosis | 1 | 2021 | 2968 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2017 | 2575 | 0.070 |
Why?
|
| Proteoglycans | 2 | 2001 | 835 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 6171 | 0.070 |
Why?
|
| Vinblastine | 5 | 1988 | 502 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2012 | 970 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 538 | 0.070 |
Why?
|
| Diptera | 1 | 2007 | 53 | 0.070 |
Why?
|
| Dogs | 2 | 2004 | 3912 | 0.070 |
Why?
|
| Mice, Transgenic | 5 | 2005 | 9734 | 0.070 |
Why?
|
| Cross Reactions | 6 | 1988 | 841 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 2957 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 1995 | 1488 | 0.070 |
Why?
|
| Secondary Prevention | 2 | 2010 | 1530 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 1995 | 1901 | 0.070 |
Why?
|
| Urinary Tract | 1 | 2010 | 309 | 0.070 |
Why?
|
| Blood Proteins | 1 | 1991 | 1124 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3768 | 0.070 |
Why?
|
| Swine | 2 | 2019 | 5917 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 3 | 2015 | 655 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 1998 | 659 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3023 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2015 | 1859 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2004 | 813 | 0.070 |
Why?
|
| Iron | 1 | 2014 | 1774 | 0.070 |
Why?
|
| Lectins | 2 | 1988 | 513 | 0.070 |
Why?
|
| Lymphocytes | 2 | 2009 | 2617 | 0.070 |
Why?
|
| Collagen | 2 | 2012 | 2689 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2003 | 2203 | 0.060 |
Why?
|
| Receptors, Antigen | 1 | 1985 | 53 | 0.060 |
Why?
|
| UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Child | 13 | 2010 | 77709 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2011 | 507 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 354 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2886 | 0.060 |
Why?
|
| Asia, Central | 1 | 2004 | 12 | 0.060 |
Why?
|
| Salmonella typhimurium | 2 | 1998 | 351 | 0.060 |
Why?
|
| Proteome | 1 | 2014 | 1799 | 0.060 |
Why?
|
| Europe, Eastern | 1 | 2004 | 75 | 0.060 |
Why?
|
| DNA Topoisomerase IV | 1 | 2004 | 41 | 0.060 |
Why?
|
| Serum | 1 | 2005 | 214 | 0.060 |
Why?
|
| Octoxynol | 1 | 2004 | 77 | 0.060 |
Why?
|
| Organic Chemicals | 1 | 2005 | 211 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 562 | 0.060 |
Why?
|
| Americas | 1 | 2004 | 111 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10943 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2004 | 12208 | 0.060 |
Why?
|
| Heptoses | 1 | 2003 | 8 | 0.060 |
Why?
|
| Oligosaccharides, Branched-Chain | 1 | 2003 | 5 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 1992 | 1170 | 0.060 |
Why?
|
| Deoxy Sugars | 1 | 2003 | 20 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2003 | 15 | 0.060 |
Why?
|
| Rhamnose | 1 | 2003 | 18 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 428 | 0.060 |
Why?
|
| Sugar Acids | 1 | 2003 | 24 | 0.060 |
Why?
|
| Chemistry | 4 | 1986 | 352 | 0.060 |
Why?
|
| Cyclodextrins | 1 | 2004 | 57 | 0.060 |
Why?
|
| Chemical Phenomena | 4 | 1986 | 518 | 0.060 |
Why?
|
| Polysaccharide-Lyases | 2 | 1993 | 48 | 0.060 |
Why?
|
| Isomerism | 1 | 2003 | 201 | 0.060 |
Why?
|
| Child, Preschool | 6 | 2010 | 41006 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2505 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2003 | 305 | 0.060 |
Why?
|
| Lethal Dose 50 | 1 | 2003 | 77 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 565 | 0.060 |
Why?
|
| Inflammation | 5 | 2018 | 10638 | 0.060 |
Why?
|
| Rats | 6 | 2017 | 24260 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2006 | 645 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 2011 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2004 | 378 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 986 | 0.050 |
Why?
|
| Magnesium | 3 | 2014 | 813 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 216 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 1991 | 1736 | 0.050 |
Why?
|
| Burns | 5 | 2000 | 1815 | 0.050 |
Why?
|
| Conjugation, Genetic | 2 | 1993 | 126 | 0.050 |
Why?
|
| Lymphokines | 2 | 1991 | 949 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6314 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2008 | 1534 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3679 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 1983 | 457 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1202 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 443 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2003 | 227 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 116 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 1085 | 0.050 |
Why?
|
| Monocytes | 3 | 1990 | 2596 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2008 | 5179 | 0.050 |
Why?
|
| Ligands | 2 | 2001 | 3282 | 0.050 |
Why?
|
| Kidney | 4 | 2000 | 7186 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2005 | 772 | 0.050 |
Why?
|
| Time Factors | 3 | 2013 | 40075 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1458 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2003 | 2699 | 0.050 |
Why?
|
| Adult | 20 | 2013 | 214055 | 0.050 |
Why?
|
| Sputum | 4 | 2005 | 476 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4803 | 0.050 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2000 | 10 | 0.050 |
Why?
|
| Hemagglutination Tests | 4 | 2003 | 75 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 1999 | 143 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2000 | 5021 | 0.050 |
Why?
|
| Acylation | 1 | 2000 | 107 | 0.050 |
Why?
|
| Glycoconjugates | 1 | 2020 | 87 | 0.050 |
Why?
|
| Transformation, Genetic | 1 | 2000 | 192 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 928 | 0.050 |
Why?
|
| Longevity | 1 | 2008 | 1070 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1375 | 0.040 |
Why?
|
| Lipid Bilayers | 1 | 2002 | 381 | 0.040 |
Why?
|
| Gene Expression | 2 | 2005 | 7799 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2018 | 4011 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 1572 | 0.040 |
Why?
|
| Infant | 4 | 2010 | 35136 | 0.040 |
Why?
|
| Phenotype | 6 | 2009 | 16365 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 2007 | 1743 | 0.040 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1982 | 238 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 426 | 0.040 |
Why?
|
| B-Lymphocytes | 6 | 1993 | 4665 | 0.040 |
Why?
|
| Immunity, Active | 1 | 1978 | 60 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2021 | 599 | 0.040 |
Why?
|
| Adolescent | 9 | 2010 | 85781 | 0.040 |
Why?
|
| Lymphocyte Cooperation | 2 | 1989 | 112 | 0.040 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1998 | 59 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 101 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 12072 | 0.040 |
Why?
|
| Homozygote | 1 | 2003 | 1785 | 0.040 |
Why?
|
| Quinolones | 1 | 2022 | 367 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2171 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 2021 | 3200 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1999 | 361 | 0.040 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1998 | 173 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 1985 | 1547 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9648 | 0.040 |
Why?
|
| Pancreatic Elastase | 2 | 1990 | 136 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 56430 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2969 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2003 | 13033 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2017 | 810 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 2017 | 81 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 3772 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2021 | 669 | 0.040 |
Why?
|
| Glucose | 3 | 2014 | 4397 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1917 | 0.040 |
Why?
|
| Burkholderia | 1 | 2017 | 38 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3701 | 0.040 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2017 | 120 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1993 | 4320 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3920 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6365 | 0.030 |
Why?
|
| Immunodiffusion | 3 | 1985 | 163 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3144 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2004 | 3002 | 0.030 |
Why?
|
| Jejunum | 1 | 1998 | 480 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 1995 | 92 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 482 | 0.030 |
Why?
|
| Plasma | 1 | 2019 | 575 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2003 | 9146 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2017 | 281 | 0.030 |
Why?
|
| CHO Cells | 1 | 1998 | 1406 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13408 | 0.030 |
Why?
|
| Cholic Acids | 1 | 2014 | 41 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 1 | 1996 | 282 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2017 | 698 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2017 | 500 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 380 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1995 | 277 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2014 | 131 | 0.030 |
Why?
|
| Cricetinae | 1 | 1998 | 2472 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2004 | 4217 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2014 | 252 | 0.030 |
Why?
|
| Detergents | 1 | 2014 | 230 | 0.030 |
Why?
|
| Sonication | 1 | 2014 | 83 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2088 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2016 | 3689 | 0.030 |
Why?
|
| Acute Disease | 1 | 2004 | 7149 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 8301 | 0.030 |
Why?
|
| Pleurisy | 1 | 1993 | 53 | 0.030 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2013 | 94 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 1102 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 720 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 1993 | 78 | 0.030 |
Why?
|
| Mitogens | 2 | 1985 | 232 | 0.030 |
Why?
|
| Acridine Orange | 1 | 1992 | 26 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2001 | 4740 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.030 |
Why?
|
| Galactosamine | 1 | 2012 | 30 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2132 | 0.030 |
Why?
|
| Oxygen | 1 | 2004 | 4189 | 0.030 |
Why?
|
| Liver | 2 | 2016 | 7474 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1526 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 829 | 0.030 |
Why?
|
| Oxacillin | 1 | 2012 | 42 | 0.030 |
Why?
|
| Kinetics | 3 | 2005 | 6473 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 5867 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2007 | 23403 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 878 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1993 | 803 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2012 | 69 | 0.030 |
Why?
|
| Periodontitis | 1 | 2017 | 553 | 0.030 |
Why?
|
| Immune Tolerance | 4 | 1990 | 2258 | 0.030 |
Why?
|
| Alleles | 1 | 2003 | 6933 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 528 | 0.030 |
Why?
|
| Leukocytes | 2 | 1992 | 2043 | 0.030 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2012 | 47 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1989 | 363 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 2013 | 1588 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2012 | 140 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 436 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2010 | 21746 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5892 | 0.030 |
Why?
|
| Age Factors | 3 | 2019 | 18370 | 0.020 |
Why?
|
| Epidemics | 1 | 2017 | 523 | 0.020 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2012 | 137 | 0.020 |
Why?
|
| Lymphocyte Activation | 3 | 1988 | 5524 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 1903 | 0.020 |
Why?
|
| Syndecans | 2 | 2001 | 79 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1990 | 1157 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 976 | 0.020 |
Why?
|
| Isodesmosine | 1 | 2010 | 6 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2002 | 8436 | 0.020 |
Why?
|
| Desmosine | 1 | 2010 | 19 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 549 | 0.020 |
Why?
|
| French Guiana | 1 | 2010 | 45 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 1988 | 2988 | 0.020 |
Why?
|
| Sheep | 2 | 2009 | 1437 | 0.020 |
Why?
|
| Hot Temperature | 2 | 2008 | 1354 | 0.020 |
Why?
|
| Agranulocytosis | 2 | 1988 | 101 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 20947 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3508 | 0.020 |
Why?
|
| Alanine | 1 | 2012 | 572 | 0.020 |
Why?
|
| Colon | 1 | 1998 | 1772 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 690 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1990 | 156 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 15519 | 0.020 |
Why?
|
| Australia | 1 | 2013 | 1170 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2013 | 772 | 0.020 |
Why?
|
| Toxoids | 1 | 1989 | 12 | 0.020 |
Why?
|
| Elapid Venoms | 1 | 1989 | 40 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.020 |
Why?
|
| Haptens | 1 | 1989 | 166 | 0.020 |
Why?
|
| Vibrio cholerae | 1 | 2015 | 806 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 413 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 1989 | 467 | 0.020 |
Why?
|
| France | 1 | 2010 | 517 | 0.020 |
Why?
|
| Azides | 1 | 2008 | 116 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 4420 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 440 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3479 | 0.020 |
Why?
|
| Silicone Elastomers | 1 | 1988 | 84 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2018 | 2948 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2009 | 131 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1988 | 104 | 0.020 |
Why?
|
| Bacteriolysis | 1 | 2008 | 51 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1999 | 2149 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 218 | 0.020 |
Why?
|
| Peptides | 1 | 2000 | 4409 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2016 | 3206 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 1988 | 264 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2008 | 624 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1988 | 290 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1995 | 3913 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1994 | 780 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2009 | 276 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 847 | 0.020 |
Why?
|
| Sigma Factor | 1 | 2008 | 175 | 0.020 |
Why?
|
| Cattle | 1 | 2013 | 3922 | 0.020 |
Why?
|
| Salmonella enterica | 1 | 2007 | 75 | 0.020 |
Why?
|
| Absorption | 1 | 1986 | 248 | 0.020 |
Why?
|
| Fimbriae, Bacterial | 1 | 1987 | 138 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4149 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2013 | 1790 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 667 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 1987 | 163 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1987 | 238 | 0.020 |
Why?
|
| Bacteriological Techniques | 2 | 2004 | 277 | 0.020 |
Why?
|
| Milk | 1 | 2009 | 450 | 0.020 |
Why?
|
| Staphylococcal Protein A | 1 | 1985 | 40 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 96 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1985 | 80 | 0.020 |
Why?
|
| Adhesiveness | 1 | 1985 | 53 | 0.020 |
Why?
|
| Glycosylation | 1 | 2008 | 1126 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2008 | 588 | 0.020 |
Why?
|
| Lipids | 2 | 1990 | 3305 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 156 | 0.020 |
Why?
|
| Rickettsial Vaccines | 1 | 1984 | 1 | 0.020 |
Why?
|
| Limulus Test | 1 | 1984 | 19 | 0.020 |
Why?
|
| Magnesium Chloride | 1 | 1984 | 32 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5097 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2005 | 164 | 0.020 |
Why?
|
| Colorimetry | 1 | 2005 | 147 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 768 | 0.020 |
Why?
|
| Glass | 1 | 2005 | 114 | 0.020 |
Why?
|
| Cefazolin | 1 | 2005 | 96 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2007 | 362 | 0.020 |
Why?
|
| Indomethacin | 1 | 1985 | 332 | 0.020 |
Why?
|
| Plastics | 1 | 2005 | 123 | 0.020 |
Why?
|
| Bacteroides fragilis | 1 | 2005 | 212 | 0.020 |
Why?
|
| Hemagglutination | 1 | 2004 | 34 | 0.020 |
Why?
|
| Edetic Acid | 1 | 1984 | 276 | 0.020 |
Why?
|
| Knee Joint | 1 | 2013 | 1680 | 0.010 |
Why?
|
| Nitrobenzoates | 1 | 2003 | 17 | 0.010 |
Why?
|
| Abscess | 1 | 1987 | 607 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1993 | 2540 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 1616 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 407 | 0.010 |
Why?
|
| Mannans | 1 | 1983 | 63 | 0.010 |
Why?
|
| Levulinic Acids | 1 | 2003 | 18 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1983 | 77 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13815 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1985 | 577 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 2513 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 25043 | 0.010 |
Why?
|
| Biomass | 1 | 2004 | 125 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 13989 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1989 | 3129 | 0.010 |
Why?
|
| Endophthalmitis | 1 | 1986 | 262 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1984 | 167 | 0.010 |
Why?
|
| Horseshoe Crabs | 1 | 1982 | 13 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 1982 | 41 | 0.010 |
Why?
|
| Hemolysis | 1 | 1984 | 420 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1993 | 4026 | 0.010 |
Why?
|
| Antigens, Ly | 3 | 1988 | 291 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1985 | 865 | 0.010 |
Why?
|
| Sex Factors | 2 | 2008 | 10397 | 0.010 |
Why?
|
| Biological Assay | 1 | 1985 | 652 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 1387 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 7023 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2013 | 63114 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15540 | 0.010 |
Why?
|
| Cell Wall | 1 | 1983 | 422 | 0.010 |
Why?
|
| Syndecan-1 | 1 | 2001 | 165 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1983 | 936 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2001 | 225 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1137 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3462 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4364 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1981 | 394 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2000 | 537 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1978 | 352 | 0.010 |
Why?
|
| Calcium | 1 | 2011 | 5756 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1855 | 0.010 |
Why?
|
| Cell Communication | 1 | 1985 | 1621 | 0.010 |
Why?
|
| Computational Biology | 1 | 2009 | 3521 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1985 | 1826 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 1801 | 0.010 |
Why?
|
| H-2 Antigens | 2 | 1988 | 366 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 9849 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1990 | 6256 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 3778 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6489 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1987 | 906 | 0.010 |
Why?
|
| Heparin | 1 | 2001 | 1637 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1993 | 116 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1981 | 1809 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15076 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1991 | 78 | 0.010 |
Why?
|
| Permeability | 1 | 1993 | 738 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13284 | 0.010 |
Why?
|
| Endothelium | 1 | 1993 | 778 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1991 | 158 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2010 | 77449 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1988 | 63 | 0.010 |
Why?
|
| Pentosyltransferases | 1 | 1988 | 65 | 0.010 |
Why?
|
| Wound Infection | 1 | 1991 | 242 | 0.010 |
Why?
|
| Research Design | 1 | 2004 | 5987 | 0.000 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1987 | 56 | 0.000 |
Why?
|
| Mice, Inbred CBA | 1 | 1988 | 448 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8949 | 0.000 |
Why?
|
| Mice, Inbred DBA | 1 | 1988 | 642 | 0.000 |
Why?
|
| Pregnancy | 1 | 2009 | 29144 | 0.000 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1986 | 68 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39050 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 40561 | 0.000 |
Why?
|
| Anterior Eye Segment | 1 | 1986 | 152 | 0.000 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1988 | 547 | 0.000 |
Why?
|
| Pyrogens | 1 | 1981 | 17 | 0.000 |
Why?
|
| Glucuronates | 1 | 1981 | 40 | 0.000 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1986 | 652 | 0.000 |
Why?
|
| Heterozygote | 1 | 1988 | 2804 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 72290 | 0.000 |
Why?
|
| Massachusetts | 1 | 1994 | 8663 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2004 | 53288 | 0.000 |
Why?
|
| Cell Survival | 1 | 1988 | 5882 | 0.000 |
Why?
|
| Proteins | 1 | 1993 | 6103 | 0.000 |
Why?
|
| Middle Aged | 1 | 2009 | 213383 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1994 | 25625 | 0.000 |
Why?
|